RENE Insider Trading (ReNeuron Group)
Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): £87,550
Insider Selling (Last 12 Months): GBX 0
ReNeuron Group Share Price & Price History
Current Price: GBX 26.50
Price Change: +0.30 (1.20%)
As of 08/10/2022 01:00 AM ET
A One Stop Shop for Everything Futures Trading
From RJO Futures | Ad
Whether you're looking to learn the basics of futures or are a seasoned vet looking to hone your trading skills, our Technical Analysis Guide has everything you need to succeed in today's futures markets!
Download your FREE Technical Analysis Trading Guide Today.
ReNeuron Group Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 7/12/2022 | Barbara Staehelin | Insider | Buy | 127,000 | GBX 30 | £38,100 | | |
| 10/20/2021 | Barbara Staehelin | Insider | Buy | 43,000 | GBX 115 | £49,450 | | |
The Safest Option in Trades!
From Tradewins | Ad
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.
And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!
SEC Filings (Institutional Ownership Changes) for ReNeuron Group (LON:RENE)
ReNeuron Group plc researches, develops, and commercializes cell-based therapies in the United Kingdom. The company engages in the development of CTX stem cell therapy candidate that is in the partnering stage in china and outside china for treating stroke disability; and human retinal progenitor cell therapy that is in Phase I/IIa clinical trial for treating retinitis pigmentosa, a blindness-causing disease. It also develops CTX-derived exosomes that are in the pre-clinical stage, which are Nano-sized packages of information released by CTX cells. In addition, the company licenses ReNcell products. It has a collaboration agreement with University College London to conduct research into the generation of immune cells from induced pluripotent stem cells for anti-cancer cell therapies. ReNeuron Group plc was founded in 1997 and is headquartered in Pencoed, the United Kingdom.
Read More on ReNeuron Group
Today's Range
Now: GBX 26.50
50 Day Range
MA: GBX 29.74
52 Week Range
Now: GBX 26.50
Volume
22,544 shs
Average Volume
270,949 shs
Market Capitalization
£15.12 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
Who are the company insiders with the largest holdings of ReNeuron Group?
